Isoprostanes as a tool to investigate oxidative stress in scleroderma spectrum disorders-advantages and limitations

被引：6

作者：

Cracowski, Jean-Luc ^{[1
]}

机构：

[1] Med Sch, Lab HP2, Pharmacol Lab, Grenoble, France

来源：

RHEUMATOLOGY | 2006年 / 45卷 / 07期

关键词：

D O I：

10.1093/rheumatology/kel139

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：922 / 923

页数：3

共 15 条

[1]

Identification and measurement of endogenous β-oxidation metabolites of 8-epi-prostaglandin F2α [J].

Chiabrando, C ;

Valagussa, A ;

Rivalta, C ;

Durand, T ;

Guy, A ;

Zuccato, E ;

Villa, P ;

Rossi, JC ;

Fanelli, R .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (03) :1313-1319

[2]

Isoprostanes: an emerging role in vascular physiology and disease? [J].

Cracowski, JL .

CHEMISTRY AND PHYSICS OF LIPIDS, 2004, 128 (1-2) :75-83

[3]

Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications [J].

Cracowski, JL ;

Durand, T ;

Bessard, G .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (08) :360-366

[4]

Increased urinary F2-isoprostanes in systemic sclerosis, but not in primary Raynaud's phenomenon -: Effect of cold exposure [J].

Cracowski, JL ;

Carpentier, PH ;

Imbert, B ;

Cachot, S ;

Stanke-Labesque, F ;

Bessard, J ;

Bessard, G .

ARTHRITIS AND RHEUMATISM, 2002, 46 (05) :1319-1323

[5]

Cracowski JL, 2001, ARTHRITIS RHEUM-US, V44, P1143, DOI 10.1002/1529-0131(200105)44:5<1143::AID-ANR196>3.0.CO

[6]

2-#

[7]

CRACOWSKI JL, 2006, IN PRESS FREE RAD BI

[8]

LeRoy EC, 2001, J RHEUMATOL, V28, P1573

[9]

A SERIES OF PROSTAGLANDIN-F2-LIKE COMPOUNDS ARE PRODUCED INVIVO IN HUMANS BY A NONCYCLOOXYGENASE, FREE RADICAL-CATALYZED MECHANISM [J].

MORROW, JD ;

HILL, KE ;

BURK, RF ;

NAMMOUR, TM ;

BADR, KF ;

ROBERTS, LJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) :9383-9387

[10]

OGAWA F, 2006, RHEUMAGOLOGY

← 1 2 →